SOX10 immunohistochemistry in sweat ductal/glandular neoplasms
- 20 April 2017
- journal article
- clinical trial
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 44 (6) , 544-547
Abstract
Background: SOX10 is a newer Schwannian and melanocytic marker that has generated great interest for its relative sensitivity and specificity in the diagnosis of neural crest‐derived tumors. Previous studies with SOX10 have shown positive immunohistochemical expression in cutaneous eccrine glands and negative expression in eccrine ducts, apocrine glands and hair follicles. Thus, we hypothesized that some sweat gland tumors of presumed eccrine origin would be positive for SOX10, whereas apocrine‐derived sweat gland tumors would not.Methods: A mouse monoclonal anti‐SOX10 (clone BC34: Biocare Medical; Concord, California) immunohistochemical antibody was performed on various sweat gland tumors and basal cell carcinoma.Results: SOX10 showed positivity in spiradenomas (13/13), cylindromas (9/10), hidradenoma papilliferum (10/10), syringocystadenoma papilliferum (8/10), apocrine adenomas (8/10), and negativity in poromas (0/12), syringomas (0/10), and basal cell carcinomas (0/13). There was mixed staining of hidradenomas (6/15).Conclusions: SOX10 immunohistochemistry may be of utility in distinguishing some of the varying adnexal tumors from each other, and from basal cell carcinoma (BCC), but given the staining of both apocrine and eccrine tumors, does not seem to provide information as to their origins as either eccrine or apocrine tumors.Keywords
This publication has 9 references indexed in Scilit:
- SOX10-positive salivary gland tumors: a growing list, including mammary analogue secretory carcinoma of the salivary gland, sialoblastoma, low-grade salivary duct carcinoma, basal cell adenoma/adenocarcinoma, and a subgroup of mucoepidermoid carcinomaHuman Pathology, 2016
- A Newly Developed Mouse Monoclonal SOX10 Antibody Is a Highly Sensitive and Specific Marker for Malignant Melanoma, Including Spindle Cell and Desmoplastic MelanomasArchives of Pathology & Laboratory Medicine, 2014
- Poroma: a review of eccrine, apocrine, and malignant formsInternational Journal of Dermatology, 2014
- SOX‐10 expression in cutaneous myoepitheliomas and mixed tumorsJournal of Cutaneous Pathology, 2014
- SOX10 is a novel marker of acinus and intercalated duct differentiation in salivary gland tumors: a clue to the histogenesis for tumor diagnosisLaboratory Investigation, 2013
- Value of SOX10 Immunostaining in Tumor DiagnosisAdvances in Anatomic Pathology, 2013
- Sox10: A Pan-Schwannian and Melanocytic MarkerAmerican Journal of Surgical Pathology, 2008
- Basal-Cell CarcinomaNew England Journal of Medicine, 2005
- Histology of basal cell carcinomaClinics in Dermatology, 1995